Académique Documents
Professionnel Documents
Culture Documents
CHIEF COMPLAINT
PATIENT 1
I have a patient with abdominal pain.
How do I determine the cause?
Appendicites
abdominal pain.
1
Of course, the abdominal exam is key. Inspection assesses for dis-
tention (often associated with bowel obstruction or ascites). Auscul- Mr. C reports no history of nonsteroidal antiinflamma-
tation evaluates whether bowel sounds are present. Absent bowel tory drug (NSAID), aspirin, or alcohol ingestion. He has
sounds may suggest an intra-abdominal catastrophe; high-pitched no known gallstones and no prior history of abdominal
tinkling sounds and rushes suggest an intestinal obstruction. Palpa- surgery. He reports that he is passing flatus and denies
tion should be done last. It is useful to distract the patient by contin- vomiting.
uing to talk with him or her during abdominal palpation. This allows
26
ABDOMINAL PAIN / 27
MI
PUD
Pancreatitis
Biliary disease
Biliary disease Splenic injury
Hepatitis Renal colic
AAA, abdominal aortic aneurysm; DKA, diabetic ketoacidosis; IBD, inflammatory bowel disease;
IBS, irritable bowel syndrome; MI, myocardial infarction; PID, pelvic inflammatory disease;
PUD, peptic ulcer disease.
The migration of pain to the RLQ is suggestive of appendicitis. The patients symptom complex, particularly the pains
Less likely considerations might include Crohn ileitis as well as migration, localization, and intensification are highly sug-
diverticulitis or colon cancer (both unlikely in this age group). If gestive of appendicitis. CT findings make this diagnosis
our patient were a woman, PID and ovarian pathology (ruptured likely. At this point, surgical exploration is appropriate.
ectopic pregnancy, ovarian torsion, or ruptured ovarian cyst) The patient undergoes surgery and purulent material is
would also need to be considered. found in the peritoneal cavity. A necrotic appendix is
removed, and the peritoneal cavity is irrigated. The patient
is treated with broad-spectrum antibiotics and does well
Diffuse abdominal pain that subsequently localizes
postoperatively.
and becomes more constant, suggests parietal peri-
toneal inflammation.
Appendicitis Obstruction
Liver
Gallbladder
Duodenum
Figure 32. Common sites of calculus formation. (Modified, with permission, Bateson MC. Gallbladder disease,
BMJ. 1999;318:17451748.)
Treatment
A. Cholecystectomy is recommended. 2
B. Lithotripsy is not advised. A RUQ ultrasound reveals multiple small gallstones
C. Dissolution therapies (eg, ursodiol) are reserved for nonsurgi- within the gallbladder. The common bile duct (CBD) is nor-
cal candidates. mal, and no other abnormalities are seen. A serum lipase
and LFTs are normal, and urea breath test for Helicobac-
ter pylori is negative.
MAKING A DIAGNOSIS
Have you crossed a diagnostic threshold for
Ms. Rs history suggests biliary colic. You order an ultrasound of the leading hypothesis, biliary colic? Have
the RUQ. you ruled out the active alternatives? Do
other tests need to be done to exclude the
alternative diagnoses?
40
nied by diarrhea or constipation or both of years duration. The diar-
rhea is often associated with cramps that are relieved by defecation.
30
Pain cannot be explained by structural or biochemical abnormalities.
20
Weight loss or anemia should alert the clinician to other possibilities.
New persistent changes in bowel habits (either diar-
10 rhea or constipation) should be thoroughly evalu-
ated to exclude colon cancer, inflammatory bowel
0 disease (IBD), or other process. An assumption of
09 1039 4049 5059 6069 70 79 80 89 > 90
Age (years) IBS in such patients is inappropriate.
Disease Highlights
Figure 33. Prevalence of asymptomatic gallstones by age. A. Affects 1015% of adults, women 2 times more than men.
(Reproduced, with permission, from the BMJ Publishing Group, B. Etiology is a combination of altered motility, visceral hyper-
Bateson MC. Gallbladder disease. BMJ. 1999;318:174548.) sensitivity, autonomic function, and psychological factors.
32 / CHAPTER 3
C. Symptoms often exacerbated by psychological or physical useful in selected patients and can suggest bowel
stressors inflammation or IBD.
often have a history of tobacco use, peripheral vascular disease or 3. Nonobstructive mesenteric ischemia
CAD. a. Often occurs in elderly patients with mesenteric ather-
osclerotic disease and superimposed hypotension (due
Disease Highlights to MI, HF, cardiopulmonary bypass, dialysis, or sepsis)
A. Secondary to near obstructive atherosclerotic disease of the b. May also occur after cocaine use and following
superior mesenteric artery (SMA) or celiac artery or both endurance exercise activities (eg, marathon, cycling).
B. Arterial stenosis results in an imbalance between intestinal oxy- 4. Mesenteric venous thrombosis is often secondary to portal
gen supply and demand that is accentuated after eating lead- hypertension, hypercoagulable states, and intra-abdominal
ing to intestinal angina resulting in food fear and weight loss inflammation.
C. Two or more vessels (ie, SMA and celiac artery) are involved B. Patients have acute abdominal pain that is often out of pro-
in 91% of affected patients. portion to their abdominal exam. If left untreated, bowel
infarction and peritoneal findings will develop.
Evidence-Based Diagnosis C. Incidence: 0.10.3% of hospital admissions
A. Weight loss occurs in 80% of patients and is due to food D. Mortality is high at 3065%.
aversion.
B. Although stenoses are common (18% of population over age Evidence-Based Diagnosis
65 years), symptomatic chronic ischemia is rare, and docu- A. Common presenting symptoms are abdominal pain (94%),
mented stenosis does not confirm the diagnosis of mesenteric nausea (56%), vomiting (38%), and diarrhea (31%).
ischemia. It is important to exclude more common disorders B. 50% of patients have a prior history of intestinal angina
(ie, PUD and gallstone disease).
C. The WBC is abnormal in 90% of patients and often markedly
C. Duplex ultrasonography is very sensitive (> 90%) and can be elevated. (Mean WBC 21.4 109/mL)
used as the initial diagnostic tool. Normal results make the
D. Lactate level was elevated in 7789% of patients (mean
diagnosis very unlikely.
3.3 mmol/L (normal < 2.0 mmol/L)
D. CT angiography and magnetic resonance angiography have
also been used. Angiography should be considered if the
results of noninvasive testing suggest vascular obstruction. A normal lactate level does not rule out acute
mesenteric ischemia.
Treatment
Revascularization (surgical repair or angioplasty [with stent]) is the E. Plain abdominal radiographs may reveal thickening of bowel
only treatment. loops or thumbprinting but are insensitive (40%).
F. Doppler ultrasonography is insensitive due to distended bowel.
2. Acute Mesenteric Ischemia G. Standard CT scanning may demonstrate SMA occlusion or
Textbook Presentation findings suggesting ischemic and necrosis such as segmental
bowel wall thickening or pneumatosis but is insensitive (64%).
Acute mesenteric ischemia is a life-threatening condition that vir-
tually always presents with the abrupt onset of acute severe H. Although CT angiography and magnetic resonance angiogra-
abdominal pain that is typically out of proportion to a relatively phy have been used, direct angiography is the gold standard
benign physical exam. Acute mesenteric ischemia usually occurs in and recommended.
patients with risk factors of arterial thrombosis or systemic
embolization. Treatment
A. Emergent revascularization (via thromboembolectomy, throm-
bolysis, vascular bypass or angioplasty) and surgical resection
Disease Highlights of necrotic bowel are the mainstays of therapy. Prompt surgi-
A. Usually due to SMA or celiac artery embolism (50%). Other cal intervention (< 12 hours) reduces mortality compared with
causes include thrombosis (1525%), low flow states without delayed intervention (> 12 hours) (14% vs 75%).
obstruction 2030% (nonobstructive mesenteric ischemia B. Broad-spectrum antibiotics
[NOMI]), and mesenteric venous thrombosis (5%). C. Volume resuscitation
1. Embolism D. Preoperative and postoperative anticoagulation to prevent
a. Risk factors include atrial fibrillation, acute MI, valvular thrombus propagation
heart disease, heart failure (HF), ventricular aneurysms, E. For patients with NOMI, improved perfusion is paramount.
angiography of abdominal aorta, and hypercoagulable
states. F. Intra-arterial papaverine has been used to block reactive mesen-
teric arteriolar vasoconstriction and improve blood flow.
b. The onset is often sudden without prior symptoms.
2. Thrombosis
3. Ischemic Colitis
a. Usually occurs in patients with atherosclerotic disease
of the involved artery. Textbook Presentation
b. Approximately half of such patients have a prior Ischemic colitis typically presents with left-sided abdominal pain.
history of chronic mesenteric ischemia with intes- Patients frequently have bloody or maroon stools or diarrhea.
tinal angina. Profuse bleeding is unusual.
34 / CHAPTER 3
Disease Highlights J. Vascular studies are usually normal and not indicated except
A. Usually due to nonocclusive decrease in colonic perfusion in the unusual case of isolated right-sided ischemic colitis.
B. Typically involves the watershed areas of the colon, most
commonly the splenic flexure, descending colon, and rec- Treatment
tosigmoid junction A. Therapy is primarily supportive with bowel rest, IV hydra-
C. Precipitating events may include hypotension, MI, sepsis, or tion, and broad-spectrum antibiotics.
HF, but the cause is not usually identified. B. Colonic infarction occurs in a small percentage of patients
D. Uncommon causes include vasculitis, hypercoagulable states, (1520%) and requires segmental resection.
vasoconstrictors, vascular surgery, drugs (eg, alosetron) and C. Indications for surgery include peritonitis, sepsis, free air on
long distance running or bicycling (presumably due to shunt- plain radiographs, clinical deterioration (persistent fever,
ing and hypoperfusion). increasing leukocytosis, lactic acidosis), or strictures.
dark urine is a pivotal clinical clue, which suggests a different com- Other considerations include hepatitis or pancreatitis, which
plication. One cause of dark urine is bilirubin in the urine (biliru- may be caused by CBD obstruction. While hepatitis can cause
binuria). Bilirubinuria only occurs in patients with conjugated RUQ pain, hyperbilirubinemia, and bilirubinuria, it would also
hyperbilirubinemia which, in turn, is due to either CBD obstruc- require giving Ms. R. another unrelated diagnosis and is therefore
tion or hepatitis. In our patient, the preexistent biliary colic, per- less likely. Table 35 lists the differential diagnosis.
sistent RUQ pain, and dark urine make the most likely diagnosis
CBD obstruction due to migration of a stone into the CBD
(choledocholithiasis) (Figure 32). On the other hand, in patients
with cholecystitis, only the cystic duct is obstructed. The CBD
remains open and therefore cholecystitis does not cause hyper- 2
bilirubinemia, dark urine, or significant increases in ALT (SGPT)
or AST (SGOT). Finally, Ms. Rs fever suggests that the CBD Laboratory results include WBC 17,000/mcL (84%
obstruction has been complicated by ascending infection (ascend- neutrophils, 10% bands). Hct is 38%, lipase 17 units/L
ing cholangitis), a life-threatening condition (Figure 34). (nl 1165 units/L), alkaline phosphatase 467 units/L
(nl 30120), bilirubin 4.2 mg/dL, conjugated bilirubin
Dark urine suggests bilirubinuria and may precede 3.0 mg/dL (nl 0 0.3), GGT 246 units/L (nl 835),
icterus. ALT, 100 units/L (nl 1559). Ultrasound shows
sludge and stones within the gallbladder. No CBD
dilatation or CBD stone is seen. Blood cultures are
Rigors (defined as visible shaking or teeth chattering ordered and you initiate broad-spectrum IV antibiotics
chills) suggests bacteremia and should increase the (ie, piperacillin/tazobactam).
suspicion of a life-threatening bacterial infection.
Consider
Consider biliary colic Consider cholecystitis choledocolithiasis and
ascending cholangitis or
pancreatitis if the lipase
is elevated
RUQ RUQ
ultrasound ultrasound
Consider
US, EUS,
MRCP, or ERCP
Gallstones with
Nondiagnostic gallbladder wall
thickening or edema
(+)
HIDA scan
Nonvisualization
Biliary colic Cholecystitis
of gallbladder
US, ultrasound; EUS, endoscopic ultrasound; MRCP, magnetic resonance cholangiopancreatography; ERCP, endoscopic
retrograde cholangiopancreatography
Figure 34. Diagnostic approach: biliary disease.
36 / CHAPTER 3
Table 35. Diagnostic hypotheses for Ms. R on follow-up. 1. Clinical findings in patients with cholangitis include jaun-
dice, 79%; temperature 38.0 C, 77%; and RUQ pain,
Diagnostic 68%. In various studies 4275% of patients had all three
Hypothesis Clinical Clues Important Tests (Charcot triad).
Leading Hypothesis 2. There is leukocytosis in 73% of patients and elevated
alkaline phosphatase and bilirubin in 91% and 87%,
Ascending Right upper quadrant Ultrasound respectively.
cholangitis or epigastric pain Endoscopic
3. 74% of patients were bacteremic
Dark urine ultrasound
Fever ERCP B. Choledocholithiasis
Rigors MRCP 1. Any of the following suggests choledocholithiasis and war-
CBC rants CBD evaluation (Table 36):
Blood cultures
a. Cholangitis
Active Alternatives-Most Common b. Jaundice
Acute Right upper Ultrasound c. Dilated CBD on ultrasound
cholecystitis quadrant pain d. Elevated alkaline phosphatase
Fever
e. Elevated amylase
Pancreatitis Alcohol abuse Serum lipase
Gallstones
2. CBD stones are present in 58% of patients without any
of the aforementioned risk factors.
Hepatitis Alcohol abuse Elevated ALT 3. Transabdominal ultrasound is noninvasive but not consis-
Right upper and AST tently sensitive for choledocholithiasis as opposed to its
quadrant pain Viral serologies performance in cholelithiasis (sensitivity 2581%, speci-
Nausea
ficity 8891%). A dilated CBD is seen in only 25% of
Dark urine
patients.
ERCP, endoscopic retrograde cholangiopancreatography; MRCP, magnetic reso- 4. Endoscopic retrograde cholangiopancreatography (ERCP),
nance cholangiopancreatography. magnetic resonance cholangiopancreatography (MRCP),
and endoscopic ultrasound (EUS) are highly accurate in
detecting CBD stones. These techniques share high sensi-
tivity (90100%) and specificity (90100%).
a. ERCP
Is the clinical information sufficient to make (1) Invasive procedure that allows direct cannulation
a diagnosis of ascending cholangitis? If not, of CBD and relieves obstruction via simultaneous
what other information do you need? stone extraction and sphincterotomy
(2) > 90% sensitive, 99% specific for diagnosis
(3) Requires sedation
(4) Complicated by pancreatitis in 15% of patients
Leading Hypothesis: Choledocholithiasis & (5) Preferred procedure in patients with a high pretest
Ascending Cholangitis probability of CBD stones particularly those with
jaundice and fever who need prompt relief of
Textbook Presentation obstruction
Patients typically have some form of CBD obstruction (most often
from gallstones); RUQ pain, fever, and jaundice are presenting
symptoms.
Table 36. Test characteristics for choledocholithiasis.
Disease Highlights
A. 1020% of patients with symptomatic gallstones have stones Finding Sensitivity Specificity LR+ LR
within the CBD (choledocholithiasis). Cholangitis 11% 99% 18.3 0.93
B. Patients with choledocholithiasis may be asymptomatic. Jaundice 36% 97% 10.1 0.69
C. Complications of choledocholithiasis may be the presenting
manifestations: Dilated CBD 42% 96% 6.9 0.77
on ultrasound
1. Obstruction and jaundice
2. Fever, jaundice, and leukocytosis may be present due to Elevated alkaline 57% 86% 2.6 0.65
phosphatase
ascending infection from the duodenum (ascending
cholangitis). Elevated 11% 95% 1.5 0.99
3. Pancreatitis amylase
(6) In patients less likely to have a CBD stone (ie, those Disease Highlights
with cholelithiasis and isolated elevation in alkaline A. Secondary to prolonged cystic duct obstruction (> 12 hours)
phosphatase), a less invasive test (eg, MRCP or EUS)
is an appropriate initial study. B. Persistent obstruction results in increasing gallbladder
inflammation and pain. Necrosis, infection, and gangrene
b. MRCP may occur.
(1) Noninvasive scan visualizes CBD and adjacent C. Jaundice and marked elevation of liver enzymes are seen only
structures if the stone migrates into the CBD and causes obstruction.
(2) Highly accurate for CBD stones: 90100% sensi-
tive, 88100% specific
Evidence-Based Diagnosis
c. EUS is both sensitive (8998%) and specific (9498%)
for CBD stones. A. No clinical finding is sufficiently sensitive to rule out chole-
cystitis.
(1) One study reported that EUS was more sensitive
than ERCP (97% vs 67%). 1. Fever: present in 35% of patients
(2) EUS can be converted to ERCP in patients dis- 2. Murphy sign
covered to have CBD stones. a. Sensitivity, 65%; specificity, 87%
(3) A negative EUS or MRCP would obviate the need b. LR+ = 5.0, LR = 0.4
for a more invasive ERCP. B. Laboratory findings
d. CT scanning is only 75% sensitive for choledocholithi- 1. Leukocytosis (> 10,000/mcL) is present in 63% of
asis. Two studies suggest that multi-detector CT using patients.
iotroxate (which is excreted in the biliary system) is 2. Cholecystitis does not typically cause significant increases
highly accurate for choledocholithiasis (8596% sensi- in lipase or LFTs. Such findings suggest complications of
tive, 8894% specific). pancreatitis and choledocholithiasis.
Treatment C. Ultrasound
A. IV broad-spectrum antibiotics and IV hydration 1. Findings that suggest acute cholecystitis include gall-
stones with gallbladder wall thickening, pericholecystic
B. Decompression of the biliary system, preferably via ERCP, is vital. fluid, sonographic Murphy sign, or gallbladder enlarge-
1. This should be performed emergently in patients with per- ment > 5 cm
sistent pain, hypotension, altered mental status, persistent 2. Sensitivity, 88%; specificity, 80%
high fever, WBC 20,000/mcL, bilirubin 10 mg/dL and
electively in more stable patients. 3. LR+, 4.4; LR, 0.15
2. Transhepatic stent or surgical decompression is rarely used. D. Cholescintigraphy (HIDA) scans
C. Cholecystectomy 1. Radioisotope is excreted by the liver into the biliary sys-
tem. In normal patients, the gallbladder concentrates the
isotope and is visualized.
MAKING A DIAGNOSIS 2. Nonvisualization of the gallbladder suggests cystic duct
Neither dilation of the CBD nor CBD stone can be seen on ultra- obstruction and is highly specific for acute cholecystitis
sound (but is only 25% sensitive). You still suspect choledo- (97% sensitive, 90% specific).
cholithiasis because of the jaundice and increased transaminases. 3. Nonvisualization can also be seen in prolonged fasting,
hepatitis, and alcohol abuse.
4. Useful when the pretest probability is high and the ultra-
2 sound is nondiagnostic (ie, the ultrasound demonstrates
Twenty-four hours later, blood cultures are positive for stones within the gallbladder) but no clear evidence of
Escherichia coli (consistent with ascending cholangitis). cholecystitis is seen (eg, no stones within the cystic duct
nor evidence of gallbladder wall thickening or perichole-
cystic fluid).
Have you crossed a diagnostic threshold for
the leading hypothesis, ascending cholangi- 5. Visualization of the gallbladder essentially excludes acute
tis? Have you ruled out the active alterna- cholecystitis.
tives? Do other tests need to be done to E. Ultrasound is the test of choice for following reasons:
exclude the alternative diagnoses? 1. Less expensive
2. Faster
Alternative Diagnosis: Acute Hepatitis 3. Avoids radiation
4. Can image adjacent organs
See Abnormal liver tests in Chapter 22, Jaundice and Abnormal
Liver Enzymes. F. If ultrasound is normal, consider HIDA.
G. An algorithm to the diagnosis is shown in Figure 34.
Alternative Diagnosis: Acute Cholecystitis
Textbook Presentation Treatment
Patients with acute cholecystitis should be admitted, administered
Typical symptoms of acute cholecystitis include persistent RUQ or
parenteral antibiotics, and undergo cholecystectomy.
epigastric pain, fever, nausea, and vomiting.
38 / CHAPTER 3
Alternative Diagnosis: Acute Pancreatitis d. C-reactive protein > 150 mg/L at 48 hours can also
predict severe pancreatitis; sensitivity 85%, specificity
Textbook Presentation 74%; LR+ 3.2, LR 0.2
Patients with acute pancreatitis often complain of a constant and
boring abdominal pain of moderate to severe intensity that devel- Evidence-Based Diagnosis
ops in the epigastrium and may radiate to the back. Associated
symptoms may include nausea, vomiting, low-grade fever, and A. History and physical
abdominal distention. 1. Low-grade fevers (< 38.3C) are common (60%).
2. Pain may radiate to the back (50%) and may be exacer-
Disease Highlights bated in the supine position.
A. Etiology 3. Nausea and vomiting are usually present (75%).
1. Alcohol abuse (typically binge drinking) and choledo- 4. Rebound is rare on presentation; guarding is common
cholithiasis cause 80% of acute pancreatitis cases. (50%).
2. 1525% of cases are idiopathic (67% of patients with 5. Periumbilical bruising (Cullen sign) is rare.
idiopathic pancreatitis were found to have small gallstones 6. Flank bruising (Turner sign) is rare.
at ERCP) B. Laboratory studies
3. Post ERCP 1. Lipase
4. Drugs commonly associated with pancreatitis include aza- a. 94% sensitive, 96% specific; LR+ = 23, LR = .06
thioprine, didanosine (DDI), estrogens, furosemide,
hydrochlorothiazide, L-asparaginase, metronidazole, opi- b. Remains elevated longer than serum amylase
oids, pentamidine, sulfonamides, corticosteroids, tamox- c. Marked elevations suggest pancreatitis secondary to
ifen, tetracycline, valproate, and many others. gallstones.
5. Less common causes include trauma, marked hyper- 2. Amylase
triglyceridemia (> 1000 mg/dL), hypercalcemia, ischemia, a. Less sensitive and specific than lipase
HIV infection, other infection, trauma, pancreatic carci-
b. Should not be routinely ordered if lipase available
noma, pancreatic divisum and organ transplantation.
3. LFTs
6. Regardless of the inciting event, trypsinogen is activated to
trypsin, which activates other pancreatic enzymes resulting a. Useful in detecting gallstone-associated pancreatitis
in pancreatic autodigestion and inflammation (which may (GAP); patients with GAP have high risk of recurrent
become systemic and lethal). Interleukins contribute to pancreatitis and require cholecystectomy.
the inflammation. b. Studies suggest that significant elevations of the biliru-
B. Complications may be local or systemic. Severe, potentially bin, alkaline phosphatase, ALT, or AST predict GAP.
fatal pancreatitis develops in about 20% of patients. (These enzymes increase due to concomitant obstruc-
tion of the CBD.)
1. Local complications
(1) ALT or AST elevations > 100 suggest GAP (sensi-
a. Pancreatic pseudocyst
tivity 55%, specificity 93%; LR+ 89)
b. Pancreatic necrosis
(2) AST levels < 50 make GAP unlikely. (sensitivity
c. Infections 90%, specificity 68%; LR 0.15)
(1) Infected pancreatic pseudocyst (abscess) (3) 10% of patients with GAP have normal levels of
(2) Infected pancreatic necrosis alkaline phosphatase, bilirubin, AST, and ALT.
(3) Ascending cholangitis (in patients with gallstone- 4. Plain radiography is useful to rule out free air or SBO.
associated pancreatitis) 5. Imaging: A variety of imaging techniques can be used in
2. Systemic complications patients with acute pancreatitis.
a. Hyperglycemia a. Transabdominal ultrasound is noninvasive and should
b. Hypocalcemia be performed in all patients with pancreatitis to deter-
mine if they have gallstones or CBD dilatation sug-
c. Acute respiratory distress syndrome gesting GAP.
d. Acute renal failure b. CT scanning is 8790% sensitive and 9092% specific
e. Disseminated intravascular coagulation for the diagnosis of acute pancreatitis but insensitive
3. Death for determining whether or not patients have GAP.
a. Usually occurs in patients with infected pancreatic (1) Should be performed when the diagnosis is unclear
necrosis and in patients in whom multiple organ dys- or complications are suspected (pseudocysts or
function develops. pancreatic necrosis)
b. Several predictive scores have been developed including (2) Pancreatic necrosis should be suspected in patients
the Ranson criteria and Apache II score. These are with severe pancreatitis, when signs of sepsis are
fairly complex to use. present, and in patients in patients who do not
improve in the first 72 hours.
c. Hemoconcentration (Hct 50%) on admission pre-
dicts severe pancreatitis; LR+ 7.5 (vs 0.4 for patients (3) IV contrast is required to demonstrate necrosis.
with Hct ( 45%). c. Detecting GAP
ABDOMINAL PAIN / 39
(1) Neither transabdominal ultrasound nor CT are B. IV fluid is critical to maintain appropriate BP and urinary
sensitive at detecting choledocholithiasis (21% and output (> 0.5 mL/kg/h)
40% respectively). C. No oral intake
(2) MRCP is highly accurate for choledocholithiasis D. Parenteral pain medication
(8094% sensitive) as are EUS and ERCP ( 98%
sensitive) E. Nasogastric (NG) tube if recurrent vomiting
(3) ERCP can relieve CBD obstruction and is recom- F. ICU admission for severe pancreatitis
mended in patients with persistent obstruction or G. Prophylactic antibiotics for patients with pancreatic necrosis
cholangitis. Some authorities also recommend are controversial.
ERCP for patients with severe pancreatitis. ERCP H. If infection is suspected (due to increasing fever, leukocytosis
can precipitate pancreatitis and is therefore not rec- or deterioration) evaluate with fine-needle aspiration and cul-
ommended for all patients with GAP. ERCP with ture. If infection is confirmed, broad-spectrum antibiotics
sphincterotomy can be therapeutic but is invasive. should be administered and surgical debridement considered.
(4) Figure 35 outlines an approach to GAP. I. ERCP and sphincterotomy (see above)
J. Patients with GAP are at high risk for recurrent pancreatitis
Treatment ( 30%), cholangitis, and biliary colic. Cholecystectomy
A. Vital signs, orthostatic BPs, and urinary output should be should be performed after recovery and prior to discharge to
carefully monitored to assess intravascular volume. prevent recurrences. Intraoperative cholangiogram or ERCP
is required to ensure that the CBD is clear of stones.
Acute pancreatitis
No
Consider
EUS or MRCP
(+)
Conservative management
Elective cholecystectomy with intraperative cholangiogram
or ERCP
Gallstone diseases
Diagnostic
PATIENT 3 Hypothesis Clinical Clues Important Tests
Mr. J is a 63-year-old man with severe abdominal pain for Leading Hypothesis
48 hours. The pain is periumbilical with severe crampy Bowel Inability to pass stool Abdominal
exacerbations that last for several minutes and then obstruction or flatus radiographs
subside. He notes loud intestinal noises (borborygmi) Nausea, vomiting CT scan
during the periods of increased pain. The pain is associ- Prior abdominal surgery
ated with nausea and vomiting. He reports decreased or altered bowel habits,
appetite with no oral intake in the last 48 hours. Hematochezia,
Abdominal distention,
At this point, what is the leading hypothesis, hyperactive bowel
what are the active alternatives, and is there sounds (with tinkling)
a must not miss diagnosis? Given this dif- or hypoactive bowel
sounds
ferential diagnosis, what tests should be
Prior abdominal surgery
ordered?
Active AlternativesMost Common
Biliary colic Episodic, crampy pain Ultrasound
Dark urine
PRIORITIZING THE DIFFERENTIAL DIAGNOSIS
Renal colic Flank or groin pain Urinalysis
Mr. Js severe crampy abdominal pain suggests some type of vis- Hematuria Renal CT scan
ceral obstruction. The syndromes associated with pain of this
quality include ureteral obstruction secondary to kidney stones,
biliary obstruction, or intestinal obstruction (large or small
bowel). The associated nausea and vomiting can be seen with any
of those diseases. However, the loud intestinal sounds associated
with exacerbations of the pain suggest some form of intestinal Cardiac and lung exams are unremarkable. Abdominal
obstruction. In addition, the periumbilical location is more sug- exam reveals prominent distention. Bowel sounds show
gestive of intestinal obstruction than renal or biliary colic. intermittent rushes. He has mild diffuse tenderness to
Table 37 lists the differential diagnoses for Mr. J. exam without rebound or guarding. Stool is brown and
heme positive.
Disease Highlights C. Plain radiography may show air-fluid levels and distention of
Etiology and related prevalence is as follows: large bowel (> 6 cm).
1. 84% sensitive, 72% specific for presence of LBO (not
1. Cancer, 53% etiology)
2. Sigmoid or cecal volvulus, 17% 2. Small bowel distention also occurs if ileocecal valve is
3. Diverticular disease, 12% incompetent.
4. Extrinsic compression from metastatic cancer, 6% D. Barium enema (water soluble) or colonoscopy
5. Other, 12% (adhesions rarely cause LBO) 1. Barium enema is highly accurate for LBO.
42 / CHAPTER 3
a. 96% sensitive, 98% specific 2. Malignant tumor 1020%; usually metastatic. 39% of
b. LR+ 48, LR 0.04 SBOs in patients with a prior malignancy are due to adhe-
sions or benign causes.
2. Can determine etiology preoperatively (if patient stable)
3. Hernia (ventral, inguinal, or internal) 10%
3. Can exclude acute colonic pseudo-obstruction (distention
of the cecum and colon without mechanical obstruction) 4. IBD (with stricture) 5%
4. Colonoscopy can decompress pseudo-obstruction and 5. Radiation
prevent cecal perforation. 6. Less common causes of SBO include gallstones, bezoars,
E. CT scan is also accurate in the diagnosis of LBO. and intussusception.
1. 91% sensitive, 91% specific D. SBOs may be partial or complete.
2. LR+ 10.1, LR 0.1 1. Complete SBO
a. 2040% progress to strangulation and infarction
Treatment of LBO b. Clinical signs do not allow for identification of stran-
gulation prior to infarction: Fever, leukocytosis, and
A. Aggressive rehydration and monitoring of urinary output is metabolic acidosis are late signs of strangulation and
vital. suggest infarction.
B. Broad-spectrum antibiotics advised: 39% of patients have c. 5075% of patients admitted for SBO require surgery
microorganisms in the mesenteric nodes
2. Partial SBO
C. Surgery
a. Rarely progresses to strangulation or infarction
D. For patients with sigmoid volvulus, and no evidence of infarc-
tion, sigmoidoscopy allows decompression and elective sur- b. Characterized by continuing ability to pass stool or fla-
gery at a later date to prevent recurrence. tus (> 612 hours after symptom onset) or passage of
contrast into cecum
1. Emergent indications: perforation or ischemia
c. Resolves spontaneously (without surgery) in 6085%
2. Nonemergent indications: increasing distention, failure to of patients
resolve
d. Enteroclysis (an air-contrast study of the small bowel)
is test of choice.
MAKING A DIAGNOSIS e. CT scan only 48% sensitive for partial SBO
Evidence-Based Diagnosis
3
A. Ideally, tests for SBO should identify obstruction and
After reviewing the plain films, you order a barium enema. ischemia or infarction, if present (since ischemia and infarc-
tion are indications for emergent surgery rather than further
Have you crossed a diagnostic threshold for observation.) Unfortunately, even tests that successfully pre-
the leading hypothesis, large bowel obstruc- dict SBO do not reliably determine whether there is ischemia
tion? Have you ruled out the active alterna- and infarction.
tives? Do other tests need to be done to B. See test characteristics of history and physical exam under
exclude the alternative diagnoses? LBO.
C. WBC may be normal even in presence of ischemia.
D. Plain radiographs may show two air-fluid levels or dilated
loops of bowel proximal to obstruction (> 2.5 cm diameter of
Alternative Diagnosis: SBO small bowel).
1. Sensitivity for obstruction 5993%, specificity 83%
Textbook Presentation
2. Rarely determines etiology
The presentation is similar to that for LBO with the exception
that more patients have a history of prior abdominal surgery. 3. Complete obstruction is unlikely in patients with air in
the colon or rectum
E. Ultrasound is seldom used for this indication but may be use-
Disease Highlights ful in pregnant patients.
A. Bowel obstruction accounts for 4% of patients with abdomi- F. CT scanning
nal pain.
1. Moderately sensitive at determining high-grade obstruc-
B. SBO accounts for 80% of all bowel obstructions. tion (8093%).
C. Etiology a. Obstruction is suggested by a transition point between
1. Adhesions present in 70% of cases bowel proximal to the obstruction, which is dilated,
a. Usually postsurgical and bowel distal to the obstruction, which is collapsed.
b. 93% of patients with prior abdominal surgery have b. CT scanning should be performed prior to NG suction,
adhesions which may decompress the proximal small bowel and
thereby decreases the sensitivity of the CT scan for SBO.
c. Up to 14% of patients with prior surgery require read-
mission for adhesions over the next 10 years. 2. May delineate etiology of obstruction
ABDOMINAL PAIN / 43
3. Test of choice to diagnose SBO (not ischemia) B. Careful, frequent observation and repeated physical exam
4. Not reliably sensitive at determining the presence of over the first 1224 hours
ischemia and infarction (and the need for immediate sur- C. NG suction
gery). Different studies have reported sensitivities ranging D. Broad-spectrum antibiotics (59% of patients have bacterial
from 15% to 100% (specificity 8594%). translocation to mesenteric lymph nodes)
E. Frequent plain radiographs and CBC
The absence of CT signs of ischemia in patients
with SBO does not in fact rule out ischemia. F. Indications for surgery include any of the following
1. Signs of ischemia (increased pain, fever, tenderness, peri-
toneal findings, acidosis, or worsening leukocytosis)
G. Small bowel series
2. CT findings of infarction
1. Accurate in the diagnosis of SBO and useful to predict
3. SBO secondary to hernia
nonoperative resolution; 4596% sensitive, 9296% spe-
cific. (Spontaneous resolution likely in patients in whom 4. SBO clearly not secondary to adhesion (no prior surgery)
contrast reaches the colon) 5. Some clinicians recommend surgery when bowel obstruc-
2. Unlike CT scanning, small bowel series cannot delineate tion fails to resolve in 24 hours. Others suggest a small
etiology of SBO or demonstrate ischemic changes. bowel study.
3. Typically used when CT scanning not diagnostic and con-
cern for SBO remains
4. Water-soluble contrast and barium have been used CASE RESOLUTION
a. Barium is superior because it is not diluted by intralu-
minal water.
b. Barium can become inspissated in the colon and is con-
traindicated in LBO. 3
The barium enema reveals an obstructive apple core
Treatment lesion in the sigmoid colon suggestive of carcinoma of the
A. Fluid resuscitation colon. Mr. J underwent surgical exploration, which con-
1. Intravascular dehydration is often prominent due to firmed an obstructing colonic mass. The mass was
decreased oral intake, vomiting, and third spacing of fluid resected and a colostomy created. Pathologic evaluation
within the bowel. revealed adenocarcinoma of the colon.
2. Monitor urinary output carefully.
g. Therapy includes smoking cessation and repair of b. For AAA 4.05.4 cm, monitor every 6 months with
aneurysms 5.5 cm. Immunosuppressants (ie, corti- ultrasonography. One report suggested increasing the
costeroids) have been used. frequency to every 3 months in patients with aneurysms
D. Risk factors 5.0 cm.
1. Smoking is the most significant risk factor (OR 5). 5. Medical management includes smoking cessation, statin
therapy, and blood pressure control.
2. Men are affected 4 to 5 times more often than women.
3. Family history of AAA (OR 4.3)
MAKING A DIAGNOSIS
4. Increased age
5. Hypertension (OR 1.2)
Evidence-Based Diagnosis 4
A. Physical exam is not sufficiently sensitive to rule out AAA. Further evaluation at this point depends on the index of
suspicion. If AAA is very likely and the patient is unsta-
B. Bruits do not contribute to diagnosis. ble, many vascular surgeons proceed directly to the oper-
C. Sensitivity of focused exam for asymptomatic AAA is poor ating room without further studies in order to avoid the
overall (39%) and only 76% among patients with large AAA potential lethal delay of obtaining a CT scan. Bedside
( 5 cm.) The sensitivity of the physical exam is less in obese ultrasonography is a useful option if available. If AAA is
patients. less likely and the patient is stable, CT scanning is appro-
D. Sensitivity of abdominal exam in symptomatic AAA priate.
1. Abdominal pain, distention, and rupture all limit sensitivity.
Have you crossed a diagnostic threshold for
2. Distention was reported in 52100% in different series. the leading hypothesis, AAA? Have you ruled
3. Palpable mass was found in 18%. out the active alternatives? Do other tests
need to be done to exclude the alternative
A palpable mass is unusual in patients with a rup- diagnoses?
tured AAA.
2. Supersaturation is secondary to a combination of increased 2. A more comprehensive evaluation, including several 24-
urinary salt excretion combined with inadequate diluting hour urine specimens for analysis of calcium, oxalate, uric
urinary volume. Numerous mechanisms can contribute to acid, sodium, creatinine and citrate as well as submission
an increase in urinary mineral excretion including: of retrieved stones for chemical analysis, is recommended
a. Calcium: idiopathic hypercalcuria, primary hyper- for patients with recurrent stones. Some experts recom-
parathyroidism, immobilization, excessive sodium mend this for patients with their first stone.
intake (which increases calcium excretion), systemic
acidosis, hypocitraturia (a factor in 2060% of calcium Treatment
stones), and excessive vitamin D supplementation
A. Pain control
b. Uric acid: Excessive dietary purines, myeloproliferative
1. NSAIDS
disorders, uricosuric agents (for the treatment of gout),
and metabolic syndrome. Low urine pH also con- a. Treat pain and diminish spasm
tributes to uric acid stone formation. Hyperuricosuria b. Create less dependence than opioids
can lead to uric acid stones or calcium stones due to c. To be avoided 3 days before lithotripsy due to antiplatelet
heterogeneous ossification. effects
c. Oxalate: Causes include excessive dietary oxalates 2. Opioids
(rhubarb, spinach, chocolate, nuts, vitamin C) and
increased oxalate absorption (fat malabsorption com- B. Hydration (oral if tolerated, otherwise IV)
plexes calcium and leads to increased oxalate absorp- C. Sepsis or renal failure
tion and excretion). 1. Necessitate emergent drainage (via percutaneous nephros-
3. In some patients, a decrease in urinary stone inhibitors tomy tube or ureteral stent)
(urinary citrate) also contribute to stone formation. 2. For sepsis, broad-spectrum IV antibiotics to cover gram-neg-
4. Infection with urea splitting organisms (ie, Proteus) plays a ative organisms and enterococcus should be administered
key role in the formation of struvite stones (MgNH4PO4). D. Stone passage
5. Renal colic develops when stones dislodge from the kidney 1. Nifedipine and tamsulosin have been demonstrated to sig-
and obstruct urinary flow. nificantly increase the likelihood of stone passage by 65%.
D. Complications 2. Lithotripsy or ureteroscopy are used to remove persistent
1. Ureteral obstruction ureteral stones.
2. Pyelonephritis E. Secondary prevention
3. Sepsis 1. General measures include increasing fluid intake ( 2 L/d),
4. Renal failure is rare, occurring in patients with bilateral and moderating sodium and protein intake.
obstruction or obstruction of a solitary functioning kidney. 2. More specific management (ie, dietary modification) is
complex and depends on the underlying etiology of the
patients nephrolithiasis.
Evidence-Based Diagnosis 3. Thiazide diuretics decrease urinary calcium excretion (espe-
A. The evaluation is directed at establishing the diagnosis of cially when combined with potassium supplementation)
nephrolithiasis and its underlying etiology so that measures to and can be useful in patients with recurrent nephrolithiasis
prevent its recurrence can be implemented. and hypercalciuria.
B. Establishing the diagnosis 4. Allopurinol can be useful in patients with nephrolithiasis
1. Hematuria is present in 80% of patients, LR is 0.57. and hyperuricosuria.
Radiation and
Differential Quality and Associated
Location Diagnosis Frequency Symptoms Clinical Clues
RUQ Biliary disease Obstructive Back, right shoulder; Postprandial or nocturnal pain
Episodic N&V Dark urine
Pancreatitis See Epigastrium below
Renal colic: Usually Obstructive Groin; N & V Hematuria (usually microscopic)
flank pain Episodic Writhing, unable to get comfortable
LUQ Splenic infarct or Constant Left shoulder pain Endocarditis, trauma, orthostatic
rupture hypotension, shoulder pain
Epigastrium Peptic ulcer Hunger like, intermittent, Back; early satiety, Melena, history of NSAIDs;
gradual changes Food may increase or decrease pain
Pancreatitis Boring, constant Back; N & V Worse supine; history of alcohol
abuse or gallstones
Biliary disease See above
Diffuse periumbilical Appendicitis Steady, worsening; Groin; Occasionally back; Migration and progression
Migrates to RLQ N & V anorexia No prior similar episodes
Bowel Obstruction Obstructive N & V anorexia Inability to pass stool or flatus, prior surgery
Mesenteric ischemia Severe Weight loss Out of proportion to exam, brought on
by food, bruit
AAA Excruciating Back Hypotension, syncope or pulsatile
abdominal mass
Irritable bowel Crampy, recurring Intermittent diarrhea, Absence of weight loss or alarm
syndrome constipation symptoms, recurring nature of symptoms
RLQ Appendicitis See Diffuse
periumbilical above
Diverticulitis Usually LLQ; see below
Cecal Similar to bowel
volvulus obstruction; see above
Ovarian disease Differential includes
ovarian torsion,
Mittelschmerz, ectopic
pregnancy and PID.
LLQ Diverticulitis Persistent, increasing Back; Fever, N & V, May have prior episodes, localized tenderness
diarrhea
Ovarian disease See above
Sigmoid Volvulus Similar to bowel
obstructions; see above
AAA, abdominal aortic aneurysm; LLQ, left lower quadrant; LUQ, left upper quadrant; NSAIDs, nonsteroidal antiinflammatory drugs; N & V, nausea and vomiting; PID,
pelvic inflammatory disease; RLQ, right lower quadrant; RUQ, right upper quadrant.